Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.
Npj Precision Oncology
Medford, Arielle J AJ; Dubash, Taronish D TD; Juric, Dejan D; Spring, Laura L; Niemierko, Andrzej A; Vidula, Neelima N; Peppercorn, Jeffrey J; Isakoff, Steven S; Reeves, Brittany A BA; LiCausi, Joseph A JA; Wesley, Benjamin B; Malvarosa, Giuliana G; Yuen, Megan M; Wittner, Ben S BS; Lawrence, Michael S MS; Iafrate, A John AJ; Ellisen, Leif L; Moy, Beverly B; Toner, Mehmet M; Maheswaran, Shyamala S; Haber, Daniel A DA; Bardia, Aditya A
Schrock, Alexa B AB; Devoe, Craig E CE; McWilliams, Robert R; Sun, James J; Aparicio, Thomas T; Stephens, Philip J PJ; Ross, Jeffrey S JS; Wilson, Richard R; Miller, Vincent A VA; Ali, Siraj M SM; Overman, Michael J MJ
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.
Oncotarget
Khan, Faheem Ahmed FA; Pandupuspitasari, Nuruliarizki Shinta NS; Chun-Jie, Huang H; Ao, Zhou Z; Jamal, Muhammad M; Zohaib, Ali A; Khan, Farhan Ahmed FA; Hakim, Muthia Raihana MR; ShuJun, Zhang Z
Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration samples processed as histopathological samples for genetic mutation analysis in lung adenocarcinoma.
Molecular And Clinical Oncology
Jeyabalan, Abiramy A; Bhatt, Nidhi N; Plummeridge, Martin J MJ; Medford, Andrew R L AR